berberine has been researched along with Heart Defects, Congenital in 1 studies
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, X | 1 |
| Yu, X | 1 |
| Wang, Y | 2 |
| Wang, F | 1 |
| Li, H | 1 |
| Lu, D | 1 |
| Qi, R | 1 |
| Wang, H | 1 |
1 other study available for berberine and Heart Defects, Congenital
| Article | Year |
|---|---|
Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression.
Topics: Animals; Apoptosis; Berberine; Caspase 3; Caspase 9; Doxorubicin; Embryonic Development; Female; Gen | 2012 |